日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

CIIE helps Bristol Myers Squibb expand China footprint

By Cao Chen in Shanghai | chinadaily.com.cn | Updated: 2021-06-29 16:33
Share
Share - WeChat
Visitors make inquiries at the stand of Bristol-Myers Squibb during the second China International Import Expo in Shanghai on Nov 9, 2019. [Photo by Lyu Liang/For China Daily]

The China International Import Expo has been a major platform for US biopharmaceutical enterprise Bristol-Myers Squibb to bring its experience in immuno-oncology treatment to the Chinese market and showcase its scientific and innovative achievements, said Chen Siyuan, general manager of Bristol-Myers Squibb China and Hong Kong.

At the third expo held in Shanghai last year, the company unveiled its five-year strategy tailored to the domestic market. The strategy involves accelerating the introduction of nearly 30 innovative drugs to the market, increasing the number of employees in its R&D and commercial teams, growing its investment in China and introducing the latest product lines to China to benefit more patients.

The company also reached a series of agreements with local partners in China at the third CIIE, including a contract with domestic health platform JD Health to establish an online liver disease innovation platform that would improve accessibility of the drug Baraclude, which is used to treat hepatitis B infection of the liver.

Data shows the platform helped raise online sales of the drug, which accounted for 12.5 percent of the company's sales in the first quarter.

A strategic relationship also was established between the company and Hainan Boao Lecheng International Medical Tourism Pilot Zone in South China's Hainan province. According to this partnership, the company's latest products will be first made available in the zone.

The company attended the expo for the first time in 2019 and displayed an immunotherapy drug, Opdivo. According to the company, a Nobel Prize laureate contributed to the development of this drug.

Opdivo has since been approved for use in the treatment of lung cancer, head and neck cancer, and gastric cancer in China.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 欧美久久久久久久一区二区三区 | 国产欧美日韩综合精品一区二区 | 不卡一区 | 亚洲欧美国产一区二区三区 | 日日摸夜夜爽日日摸视频 | 亚洲欧美在线视频免费 | 九九热视频免费 | 久久精品小视频 | 国产精品五区 | 欧美一二三区 | 天天色av| 一级毛片在线观看视频 | 久碰香蕉精品视频在线观看 | 欧美精品一区二区在线观看 | 日本欧美一区二区三区不卡视频 | 色男人天堂 | 特黄a大片免费视频 | 亚洲一二三区精品 | 一级性生活免费视频 | 日韩和的一区二在线 | 免费a视频在线观看 | 嘿咻嘿咻免费区在线观看吃奶 | 午夜寂寞少妇aaa片毛片 | 久久视频这里只有精品35 | 天天操操 | 亚洲美女亚洲精品久久久久 | 天天干天天干 | 一级黄片毛片免费看 | 碰碰碰人人澡人人爱摸 | 天天噜噜揉揉狠狠夜夜 | 久久久久久久久99精品 | 久草电影天堂 | 看个毛片| 免费午夜视频 | 性色网站| 欧美久久综合 | 国产欧美一区二区三区免费看 | 亚洲一区在线播放 | 国产亚洲第一伦理第一区 | 久久免费视频一区二区三区 | 国产精品一区二区三区久久 |